Screener
Estrella Immunopharma, Inc. ESLA Q2 2026 earnings
Reported August 13, 2026 · After market close
EPS-$0.05Beat by $0.04
EPS estimate-$0.09
Next report
Dec 2, 2026 (in 2 months)EPS estimate-$0.08
Versus estimates
Diluted EPS
FAQ
- When did Estrella Immunopharma, Inc. report Q2 2026 earnings?
- Estrella Immunopharma, Inc. (ESLA) reported Q2 2026 earnings on August 13, 2026 after market close.
- What were Estrella Immunopharma, Inc.'s Q2 2026 revenue and EPS?
- Estrella Immunopharma, Inc. reported eps of $-0.05 for Q2 2026.
- Did Estrella Immunopharma, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-0.09 by $0.04.
- How did Estrella Immunopharma, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 66.7% from $-0.15.
- Where can I find Estrella Immunopharma, Inc.'s Q2 2026 SEC filings?
- You can read the 10-Q periodic report (0001213900-26-089215) directly on SEC EDGAR. The filing index links above go to sec.gov.
